News

Keep up to date with what is happening, and what has happened at and around NFOG and our related events and partners.

18 August 2017

Seminars in contraception, November 9-10, 2017, Tromsø

The seminar is open for medical doctors, pharmacists, midwifes, public health nurses, and others with an interest for contraception living in the Nordic countries. When: November 9-10, 2017 Where: Scandic Ishavshotel, Tromsø, Norway Webpage Click here to register Registration dead­line: 30. september 2017 Registration will be confirmed...

Read More

23 July 2017

NOSS: Nordic Obstetric Surveillance Study

At a Nordic workshop in September 2008 funded by NFOG and NOMBIR (the Nordic Medical Birth Registries) we designed a common project to describe and analyze rare serious pregnancy complications that are reported to occur in women with a previous caesarean section. Read more...

Read More

27 June 2017

ACTA all-time high impact score

The Impact Factor of Acta Obstetricia et Gynecologica Scandinavica  has reached 2.480. AOGS publishes original research articles commentaries and reviews on all aspects of women’s health from around the globe. Recently we published a special issue on Endometriosis and its Impact on Fertility and...

Read More

8 June 2017

Presentations from NFOG Educational Course 2017: Hormones – Friend or Foe?

Metabolic changes in menopausal transition – Piltonen Premature ovarian insufficiency – Tiitinen Bleeding disorders – Dueholm Sexual dysfunction – Angelica Lindén Hirschberg HRT use in the Nordic Countries – Savolainen-Peltonen HRT- Where do we stand after WHI? Savolainen-Peltonen Hormones and cancer -risks and benefits...

Read More

23 January 2017

New president elected june 2016!

At our June 2016 meeting our new president was elected. We welcome Karen Reinhold Wøjdemann who will be serving as president of NFOG for this period. Karen is chief physician at the Bornholm hospital and has previously been the head of DSOG. She received her medical...

Read More

1 July 2013

FIGO News on Human papillomavirus vaccines

Human papillomavirus vaccines are used in many countries; globally, more than 175 million doses have been distributed. Extensive pre-­- and post-­-licensure data on the safety of the vaccines are available. Read More »

Read More